A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 893,162 shares of EW stock, worth $67.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
893,162
Previous 796,972 12.07%
Holding current value
$67.3 Million
Previous $73.6 Million 19.94%
% of portfolio
0.06%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$59.7 - $93.78 $5.74 Million - $9.02 Million
96,190 Added 12.07%
893,162 $58.9 Million
Q2 2024

Aug 12, 2024

BUY
$84.3 - $94.31 $7.42 Million - $8.3 Million
88,055 Added 12.42%
796,972 $73.6 Million
Q1 2024

May 09, 2024

BUY
$72.54 - $95.56 $8.02 Million - $10.6 Million
110,591 Added 18.48%
708,917 $67.7 Million
Q4 2023

Feb 08, 2024

BUY
$61.71 - $77.76 $2.37 Million - $2.98 Million
38,345 Added 6.85%
598,326 $45.6 Million
Q3 2023

Nov 07, 2023

BUY
$69.28 - $93.38 $3.03 Million - $4.09 Million
43,770 Added 8.48%
559,981 $38.8 Million
Q2 2023

Aug 09, 2023

BUY
$81.41 - $94.33 $1.63 Million - $1.89 Million
20,058 Added 4.04%
516,211 $48.7 Million
Q1 2023

May 08, 2023

BUY
$74.26 - $84.51 $4.03 Million - $4.58 Million
54,222 Added 12.27%
496,153 $41 Million
Q4 2022

Feb 07, 2023

BUY
$68.3 - $87.44 $3.22 Million - $4.12 Million
47,154 Added 11.94%
441,931 $33 Million
Q3 2022

Nov 01, 2022

BUY
$82.37 - $107.29 $2.93 Million - $3.81 Million
35,525 Added 9.89%
394,777 $32.6 Million
Q2 2022

Aug 04, 2022

BUY
$86.5 - $128.27 $2.52 Million - $3.74 Million
29,174 Added 8.84%
359,252 $34.2 Million
Q1 2022

May 09, 2022

BUY
$101.96 - $128.34 $2.82 Million - $3.55 Million
27,642 Added 9.14%
330,078 $38.9 Million
Q4 2021

Feb 07, 2022

BUY
$106.37 - $130.68 $4.62 Million - $5.67 Million
43,404 Added 16.76%
302,436 $38.8 Million
Q3 2021

Nov 04, 2021

BUY
$102.91 - $122.75 $2.3 Million - $2.74 Million
22,342 Added 9.44%
259,032 $29.3 Million
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $2.5 Million - $3.13 Million
29,839 Added 14.43%
236,690 $24.5 Million
Q1 2021

May 06, 2021

BUY
$78.68 - $90.67 $1.72 Million - $1.98 Million
21,830 Added 11.8%
206,851 $17.3 Million
Q4 2020

Feb 09, 2021

BUY
$71.69 - $91.23 $716,469 - $911,752
9,994 Added 5.71%
185,021 $16.9 Million
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $1.65 Million - $2.15 Million
24,614 Added 16.36%
175,027 $14 Million
Q2 2020

Aug 06, 2020

BUY
$57.54 - $76.95 $6.16 Million - $8.24 Million
107,110 Added 247.35%
150,413 $10.4 Million
Q1 2020

May 11, 2020

SELL
$52.41 - $81.0 $20,492 - $31,671
-391 Reduced 0.89%
43,303 $8.17 Million
Q4 2019

Feb 05, 2020

BUY
$71.7 - $82.09 $382,519 - $437,950
5,335 Added 13.91%
43,694 $10.1 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $94,171 - $115,407
1,530 Added 4.15%
38,359 $8.44 Million
Q2 2019

Aug 08, 2019

BUY
$55.74 - $64.41 $389,232 - $449,775
6,983 Added 23.4%
36,829 $6.8 Million
Q1 2019

Apr 26, 2019

BUY
$47.89 - $64.05 $106,220 - $142,062
2,218 Added 8.03%
29,846 $5.71 Million
Q4 2018

Feb 08, 2019

SELL
$46.41 - $56.94 $118,113 - $144,912
-2,545 Reduced 8.43%
27,628 $3.97 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $27,100 - $34,411
-593 Reduced 1.93%
30,173 $5.25 Million
Q2 2018

Aug 09, 2018

BUY
$42.45 - $51.3 $55,185 - $66,690
1,300 Added 4.41%
30,766 $4.48 Million
Q1 2018

May 02, 2018

SELL
$37.19 - $47.45 $121,536 - $155,066
-3,268 Reduced 9.98%
29,466 $4.11 Million
Q4 2017

Feb 06, 2018

BUY
$33.79 - $39.39 $47,610 - $55,500
1,409 Added 4.5%
32,734 $3.75 Million
Q3 2017

Nov 01, 2017

BUY
$36.29 - $38.83 $1.14 Million - $1.22 Million
31,325
31,325 $3.42 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.